Shockwave Medical (Shockwave Medical) 3-Year EBITDA Growth Rate : 0.00% (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Shockwave Medical 3-Year EBITDA Growth Rate?

Shockwave Medical's EBITDA per Share for the three months ended in Mar. 2024 was $1.46.

During the past 12 months, Shockwave Medical's average EBITDA Per Share Growth Rate was 31.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Shockwave Medical was 56.90% per year. The lowest was -7.10% per year. And the median was 24.90% per year.

Competitive Comparison of Shockwave Medical's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, Shockwave Medical's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shockwave Medical's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shockwave Medical's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Shockwave Medical's 3-Year EBITDA Growth Rate falls into.

Shockwave Medical 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Shockwave Medical (NAS:SWAV) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Shockwave Medical 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Shockwave Medical's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Shockwave Medical (Shockwave Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shockwave Medical Inc (NAS:SWAV) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

36M:Germany 36M:Germany

Address

5403 Betsy Ross Drive, Santa Clara, CA, USA, 95054

Website

https://www.shockwavemedical.com

ShockWave Medical Inc is a medical device company focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Its intravascular lithotripsy technology is used in the treatment of calcified plaque. Geographically, the company generates its revenue from the United States, Europe and other countries.

Executives

Douglas Evan Godshall	director, officer: President & CEO	SUITE 4 LEVEL 46 2 PARK STREET, SIDNEY C3 2000
Frank T Watkins	director	5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Isaac Zacharias	officer: Chief Commercial Officer	5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Dan Puckett	officer: CFO & Secretary	5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Trinh Phung	officer: VP, Finance	C/O SHOCKWAVE MEDICAL, INC., 5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Laura Francis	director	C/O SI-BONE, INC., 471 EL CAMINO REAL, SUITE 101, SANTA CLARA CA 95050
Sara Toyloy	director	C/O SHOCKWAVE MEDICAL, INC., 5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Kevin J. Ballinger	director	C/O BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752-1234
Maria Sainz	director	C/O ORTHOFIX INTERNATIONAL N. V., 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Antoine Papiernik	director, 10 percent owner	5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Sofinnova Capital Vii Fcpr	10 percent owner	C/O SOFINNOVA PARTNERS, 18 RUE DU 4 SEPTEMBRE, 75002 PARIS I0 00000
Cahill Colin	director	5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Frederic H Moll	director	C/O INTUITIVE SURGICAL INC, 950 KIFER ROAD, SUNNYVALE CA 94086
James E Flynn	10 percent owner, other: Possible Member of 10% Group	780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Larkin C Raymond Jr	director	C/O MALLINCKRODT INC, 7733 FORSYTH BLVD, ST LOUIS MO 63105